Actionable news
All posts from Actionable news
Actionable news in MRTX: Mirati Therapeutics, Inc.,

5 Stocks Under $10 That Could Make You a Lot of Money

Mirati Therapeutics

Another under-$10 clinical-stage biopharmaceutical player that's starting to rip within range of triggering a big breakout trade is Mirati Therapeutics (MRTX) , which develops a pipeline of products targeting oncology. This stock has been destroyed by the sellers over the last six months, with shares falling sharply by 73.8%.

If you look at the chart for Mirati Therapeutics, you'll notice that this stock ripped sharply higher on Wednesday back above both its 20-day moving average of $5.11 a share and its 50-day moving average of $5.14 a share with strong upside volume flows. Volume for that trading session registered over 470,000 shares, which is well above its three-month average action of 271,281 shares. This high-volume rip to the upside is now quickly pushing shares of Mirati Therapeutics within range of triggering a big breakout trade above some key overhead resistance levels.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in the next 12-months. Learn more.

Market players should now look for long-biased trades in Mirati Therapeutics if it manages to break out above some near-term overhead resistance levels at $5.67 to $5.82 a share and then above more resistance at$5.87 to $6...